Showing 12 of 12 recruiting trials for “hirschsprung-disease-ganglioneuroblastoma-syndrome”
Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma
Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma
👨⚕️ Tatyana V Shamanskaya, MD, PHD, Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology📍 1 site📅 Started Nov 2025View details ↗
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RecruitingNCT06590142 ↗
Hirschsprung's Advances; Working Towards Autologous tIssue therapIes
SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours
RecruitingNCT06296732 ↗
Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification
🏥 Federal Research Institute of Pediatric Hematology, Oncology and Immunology📍 1 site📅 Started Oct 2023View details ↗
Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma
🏥 Federal Research Institute of Pediatric Hematology, Oncology and Immunology📍 1 site📅 Started Sep 2023View details ↗
Impact of Providing Nursing Support on Parental Stress Related to Preoperative Care of a Newborn with Hirschsprung's Disease
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Phase II Study of Proton Radiation Therapy for Neuroblastoma
👨⚕️ Shannon M. MacDonald, MD, Massachusetts General Hospital📍 1 site📅 Started Jun 2014View details ↗
RecruitingNCT04622410 ↗
Registry for Hirschsprung Disease of the BELAPS
RecruitingNCT00478712 ↗
Hirschsprung Disease Genetic Study
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →